Processa Pharmaceuticals
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$11,121,520 over the previous period. Total operating expenses were $11,457,061.

Profit Margin

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA): Profit margin
2014 200.20K -4.52M -2260.85%
2015 113.42K -3.35M -2957.22%
2016 5K -335.98K -6719.64%
2017 0 -1.85M
2018 0 -3.76M
2019 0 -3.35M
2020 0 -14.41M
2021 0 -11.42M
2022 0 -54.84M
2023 0 -11.12M

PCSA Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
00000005K113.42K200.20K
Cost of revenue
22227.52M12.13M15.13M877.89K01.86K0125.87K113.25K
Gross profit
-222-27.52M-12.13M-15.13M-877.89K0-1.86K5K-12.45K86.95K
Operating exp.
Research and development
5.79M11.49M6.87M3.17M2.32M3.08M926.11K6.55K29.24K189.74K
Selling and marketing
000000069.96K945.46K0
Total operating expenses
11.45M20.25M11.56M6.43M3.93M4.52M1.80M76.52K974.70K3.03M
Operating income
-11.45M-27.52M-12.13M-15.13M-3.93M-4.52M-1.80M71.52K2.69M-4.16M
Other income (expenses), net
335.54K101.20K175.39K-277.94K-25.11K-142.90K-53.88K-20.26K-2.72M-1.52M
Income before tax
-11.12M-27.42M-11.95M-15.41M-3.96M-4.66M-1.85M-337.17K-2.98M-4.52M
Income tax expense
027.42M-530.61K-1.00M-602.71K-902.80K-18.18K-1.19K100100
Net income
-11.12M-54.84M-11.42M-14.41M-3.35M-3.76M-1.85M-335.98K-3.35M-4.52M
Earnings per share
Basic EPS
-8.48-3.4-0.75-38.4-12.15-0.71-8-1.47-298.4-500.8
Diluted EPS
-8.48-3.4-0.75-38.4-12.15-0.71-8-1.47-298.4-500.8
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source